Skip to main content
. 2019 Nov 7;11(11):1746. doi: 10.3390/cancers11111746

Figure 2.

Figure 2

Pairwise comparisons of toxicities: experimental therapy vs. gemcitabine alone. Data presented as odds ratio (OR) with 95% confidence interval (CI); the 95% confidence interval that did not contain the value of 1 represents as statistical significance. PLA: doublet platinum-based treatment; GEM: gemcitabine; F: fluoropyrimidine only; F-based: fluoropyrimidine-based treatment; EGFRI: epidermal growth factor receptor inhibitor; ANGI: angiogenesis inhibitor; IMT: immunotherapy; TKI: tyrosine kinase inhibitor.